Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 9/2019

01-09-2019 | Nerve Stimulation | Original Contributions

Vagal Nerve Stimulation for Glycemic Control in a Rodent Model of Type 2 Diabetes

Authors: Jieyun Yin, Feng Ji, Payam Gharibani, Jiande DZ Chen

Published in: Obesity Surgery | Issue 9/2019

Login to get access

Abstract

Background

Vagal nerve stimulation (VNS) has been reported to reduce body weight and improve sympathovagal imbalance in both basic and clinical studies. Its effects on glycemic control were however unclear. The aims of this study were to investigate the effects of VNS with various parameters on blood glucose and its possible mechanisms in rats.

Methods

A hyperglycemic rodent model induced by glucagon was used initially to optimize the VNS parameters; then, a type 2 diabetic rodent model induced by high-fat diet combined with streptozotocin was used to validate the VNS method. The VNS electrodes were implanted at the dorsal subdiaphragmatic vagus; three subcutaneous electrodes were implanted at the chest area for recording electrocardiogram in rats induced by glucagon.

Results

(1) VNS with short pulse width of 0.3 ms but not 3 ms reduced blood glucose during an oral glucose tolerance test (OGTT), with a 38.4% reduction at 15 min and 26.9% at 30 min (P < 0.05, vs. sham-VNS respectively). (2) VNS at low frequency of 5 Hz but not 14 Hz or 40 Hz reduced blood glucose during the OGTT (P < 0.05, vs. sham-VNS). (3) Intermittent VNS was more potent than continuous VNS (P < 0.01). (4) No difference was found between unilateral VNS and bilateral VNS. (5) VNS enhanced vagal activity (P = 0.005). (6) The hypoglycemic effect of VNS was blocked by glucagon-like peptide-1 (GLP-1) antagonist exendin-4.

Conclusions

VNS at 5 Hz reduces blood glucose in diabetic rats by enhancing vagal efferent activity and the release of GLP-1.
Literature
1.
Introduction: standards of medical care in diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S1-S2. Epub 2017/12/10.
2.
3.
Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics. 2010;8:29.CrossRef
4.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–7.PubMedCrossRef
5.
Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228–36.PubMedCrossRef
6.
Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009;52(1):17–30.PubMedCrossRef
7.
Zimmet P, Alberti KG. Surgery or medical therapy for obese patients with type 2 diabetes? N Engl J Med. 2012;366(17):1635–6.PubMedCrossRef
8.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.CrossRefPubMed
9.
Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.PubMedCrossRef
10.
Standards of Medical Care in Diabetes-2016: Summary of Revisions. Diabetes Care. 2016 Jan;39 Suppl 1:S4–5. Epub 2015/12/24.
11.
Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002;1(8):477–82.PubMedCrossRef
12.
13.
Grimonprez A, Raedt R, Baeken C, et al. The antidepressant mechanism of action of vagus nerve stimulation: evidence from preclinical studies. Neurosci Biobehav Rev. 2015;56:26–34.PubMedCrossRef
14.
Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 2000;47(4):276–86.PubMedCrossRef
15.
Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25(5):713–28.PubMedCrossRef
16.
17.
Bugajski AJ, Gil K, Ziomber A, et al. Effect of long-term vagal stimulation on food intake and body weight during diet induced obesity in rats. J Physiol Pharmacol. 2007;58(Suppl 1):5–12.PubMed
18.
Pardo JV, Sheikh SA, Kuskowski MA, et al. Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int J Obes. 2007;31(11):1756–9.CrossRef
19.
Sobocki J, Fourtanier G, Estany J, et al. Does vagal nerve stimulation affect body composition and metabolism? Experimental study of a new potential technique in bariatric surgery. Surgery. 2006;139(2):209–16.PubMedCrossRef
20.
Ahren B, Taborsky Jr GJ. The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog. Endocrinology. 1986;118(4):1551–7.PubMedCrossRef
21.
Li S, Zhai X, Rong P, et al. Therapeutic effect of vagus nerve stimulation on depressive-like behavior, hyperglycemia and insulin receptor expression in Zucker fatty rats. PLoS One. 2014;9(11):e112066.PubMedPubMedCentralCrossRef
22.
Malbert CH, Picq C, Divoux JL, et al. Obesity-associated alterations in glucose metabolism are reversed by chronic bilateral stimulation of the abdominal vagus nerve. Diabetes. 2017;66(4):848–57.PubMedCrossRef
23.
Ouyang X, Li S, Foreman R, et al. Hyperglycemia-induced small intestinal dysrhythmias attributed to sympathovagal imbalance in normal and diabetic rats. Neurogastroenterol Motil. 2015;27(3):406–15.PubMedCrossRef
24.
Ye F, Liu Y, Li S, et al. Hypoglycemic effects of intestinal electrical stimulation by enhancing nutrient-stimulated secretion of GLP-1 in rats. Obes Surg. 2018;4
25.
Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4):313–20.PubMedCrossRef
26.
de Bem GF, Costa CA, Santos IB, et al. Antidiabetic effect of Euterpe oleracea Mart. (acai) extract and exercise training on high-fat diet and streptozotocin-induced diabetic rats: a positive interaction. PLoS One. 2018;13(6):e0199207.PubMedPubMedCentralCrossRef
27.
Wu W, Lin L, Lin Z, et al. Duodenum exclusion alone is sufficient to improve glucose metabolism in STZ-induced diabetes rats. Obes Surg. 2018;22
28.
Yin J, Chen J, Chen JD. Ameliorating effects and mechanisms of electroacupuncture on gastric dysrhythmia, delayed emptying, and impaired accommodation in diabetic rats. Am J Physiol Gastrointest Liver Physiol. 2010;298(4):G563–70.PubMedCrossRef
29.
Bellahsene BE, Lind CD, Schirmer BD, et al. Acceleration of gastric emptying with electrical stimulation in a canine model of gastroparesis. Am J Phys. 1992;262(5 Pt 1):G826–34.
30.
Yin J, Chen J. Excitatory effects of synchronized intestinal electrical stimulation on small intestinal motility in dogs. Am J Physiol Gastrointest Liver Physiol. 2007;293(6):G1190–5.PubMedCrossRef
31.
Ionut V, Liu H, Mooradian V, et al. Novel canine models of obese prediabetes and mild type 2 diabetes. Am J Physiol Endocrinol Metab. 2010;298(1):E38–48.PubMedCrossRef
32.
Ikramuddin S, Blackstone RP, Brancatisano A, et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA. 2014;312(9):915–22.PubMedCrossRef
33.
Shikora SA, Toouli J, Herrera MF, et al. Intermittent vagal nerve block for improvements in obesity, cardiovascular risk factors, and glycemic control in patients with type 2 diabetes mellitus: 2-year results of the VBLOC DM2 study. Obes Surg. 2016;26(5):1021–8.PubMedCrossRef
34.
Gil K, Bugajski A, Kurnik M, et al. Physiological and morphological effects of long-term vagal stimulation in diet induced obesity in rats. J Physiol Pharmacol. 2009;60(Suppl 3):61–6.PubMed
35.
Gil K, Bugajski A, Thor P. Electrical vagus nerve stimulation decreases food consumption and weight gain in rats fed a high-fat diet. J Physiol Pharmacol. 2011;62(6):637–46.PubMed
36.
Val-Laillet D, Biraben A, Randuineau G, et al. Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs. Appetite. 2010;55(2):245–52.PubMedCrossRef
37.
McCallum RW, Sarosiek I, Parkman HP, et al. Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil. 2013;25(10):815–e636.PubMedPubMedCentral
38.
Yin J, Abell TD, McCallum RW, et al. Gastric neuromodulation with Enterra system for nausea and vomiting in patients with gastroparesis. Neuromodulation. 2012;15(3):224–31. discussion 31PubMedCrossRef
39.
Chen JD, Qian L, Ouyang H, et al. Gastric electrical stimulation with short pulses reduces vomiting but not dysrhythmias in dogs. Gastroenterology. 2003;124(2):401–9.PubMedCrossRef
40.
Liu J, Qiao X, Chen JD. Vagal afferent is involved in short-pulse gastric electrical stimulation in rats. Dig Dis Sci. 2004;49(5):729–37.PubMedCrossRef
41.
Chen JD, Yin J, Wei W. Electrical therapies for gastrointestinal motility disorders. Expert Rev Gastroenterol Hepatol. 2017;11(5):407–18.PubMedCrossRef
42.
Song GQ, Zhu H, Lei Y, et al. Gastric electrical stimulation optimized to inhibit gastric motility reduces food intake in dogs. Obes Surg. 2015;25(6):1047–55.PubMedCrossRef
43.
Zhu H, Sallam H, Chen DD, et al. Therapeutic potential of synchronized gastric electrical stimulation for gastroparesis: enhanced gastric motility in dogs. Am J Phys Regul Integr Comp Phys. 2007;293(5):R1875–81.
44.
Waataja JJ, Tweden KS, Honda CN. Effects of high-frequency alternating current on axonal conduction through the vagus nerve. J Neural Eng. 2011;8(5):056013.CrossRefPubMed
45.
Morton JM, Shah SN, Wolfe BM, et al. Effect of vagal nerve blockade on moderate obesity with an obesity-related comorbid condition: the ReCharge study. Obes Surg. 2016;26(5):983–9.PubMedPubMedCentralCrossRef
46.
47.
George MS, Sackeim HA, Rush AJ, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000;47(4):287–95.PubMedCrossRef
48.
Krieger JP, Arnold M, Pettersen KG, et al. Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia. Diabetes. 2016;65(1):34–43.PubMed
49.
Nakagawa A, Satake H, Nakabayashi H, et al. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci. 2004;110(1):36–43.PubMedCrossRef
50.
Metadata
Title
Vagal Nerve Stimulation for Glycemic Control in a Rodent Model of Type 2 Diabetes
Authors
Jieyun Yin
Feng Ji
Payam Gharibani
Jiande DZ Chen
Publication date
01-09-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 9/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-03901-9

Other articles of this Issue 9/2019

Obesity Surgery 9/2019 Go to the issue

Original Contributions

A 5-Year Follow-up in Children and Adolescents Undergoing One-Anastomosis Gastric Bypass (OAGB) at a European IFSO Excellence Center (EAC-BS)

Letter to the Editor

Sleeve-Jejunal Bypass as an Alternative Procedure for Managing Leakage After Laparoscopic Sleeve Gastrectomy: a Case Report

Original Contributions

Alterations in Fat Mass and Bone Mineral Density Are Associated with Decreased Lipocalin-2 After Laparoscopic Sleeve Gastrectomy in Obese Chinese Women

Multimedia Article

Modified Sleeve Gastrectomy Combined with Laparoscopic Rossetti Fundoplication and Vascularization Assessment with Indocyanine Green

Original Contributions

Effect of Sleeve Gastrectomy on Angiogenesis and Adipose Tissue Health in an Obese Animal Model of Type 2 Diabetes

Original Contributions

An Experimental Study of Intraluminal Hyperpressure Reproducing a Gastric Leak Following a Sleeve Gastrectomy